Overview
Yale Steroid Enhanced Versus Exparel Nerveblock TKA Part 2
Status:
Recruiting
Recruiting
Trial end date:
2026-03-01
2026-03-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The objective of this study is to investigate the efficacy of Dexamethasone sodium phosphate plus Methylprednisolone acetate in combination with plain bupivacaine ((B-DEX-MPA) compared with Liposomal Bupivacaine in combination with plain bupivacaine (B-LB) on post-surgical pain control among patients undergoing bilateral total knee arthroplasty (TKA) to asses if perineural B-DEX-MPA will result in superior analgesia efficacy as compared to B-LB. This study will also assess if perineural B-DEX-MPA results in improved quality of postoperative recovery as compared to B-LB.Phase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Yale UniversityCollaborator:
Department of Anesthesiology Faculty Development FundTreatments:
BB 1101
Bupivacaine
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate
Methylprednisolone
Methylprednisolone Acetate
Methylprednisolone Hemisuccinate
Prednisolone
Prednisolone acetate
Prednisolone hemisuccinate
Prednisolone phosphate
Criteria
Inclusion Criteria:- American Society of Anesthesiologists status I, II and III, elective, primary,
bilateral TKA planned for spinal anesthesia with plain 0.5% bupivacaine.
Exclusion Criteria:
- Refusal of consent
- Pregnancy
- Conditions making the patient unable to fill out questionnaire online, through email
or over the phone including with cognitive dysfunction, psychiatric disorder, or
non-English speaking patients, or lack of internet access which would prevent post
discharge follow-up electronically
- Coagulopathy
- Allergy to or for any other reasons cannot use Acetaminophen, Celebrex, local
anesthetic bupivacaine, DEX, MPA or LB
- Patients on any amounts of opioids within one month of the surgery date, any substance
abuse such as regular marijuana user (more frequent than once per month)
- Insulin dependent or uncontrolled diabetes defined as, day of surgery finger stick
glucose >200mg/dl, or HbA1C > 8.0%
- Peripheral Nerve Block site or systemic infection
- Immune compromise (e.g., HIV, chronic glucocorticoid use)
- Severe pre-existing neuropathy
- TKA for indications other than osteoarthritis such as post-traumatic injury or
rheumatoid arthritis, history of surgery in the ipsilateral knee joint, revision TKA
or bilateral TKA
- Severe hepatic or renal dysfunction (GFR <50 ml/min)
- Actual body weight <60 kg
- Patients with active or latent peptic ulcers, diverticulitis, fresh intestinal
anastomoses, and non-specific ulcerative colitis